Venrock Healthcare Capital Partners III, L.P.
Oruka Therapeutics, Inc. · 10% Owner
Venrock Healthcare Capital Partners III, L.P. is listed in filings as 10% Owner at Oruka Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 27, 2026, including purchase activity and sale activity. Recent filings connect the profile to Oruka Therapeutics, Inc. (ORKA) and KalVista Pharmaceuticals, Inc. (KALV). The current snapshot covers public activity from Feb 3, 2025 to Mar 27, 2026. Reported amounts are shown as $6.3K to $106.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $61k3.2k shares | SellMar 26, 2026 | $19.12 | $27.00 | |
| $290k15.4k shares | SellMar 26, 2026 | $18.82 | $27.00 | |
| $380k21.4k shares | SellMar 26, 2026 | $17.76 | $27.00 |